Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 0615-8505

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 0615-8505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Bupropion Xl Er Tabs 8504 8505 1)

FDA Label Image

Principal Display Panel (Bupropion Xl Er Tabs 8504 8505 2)

FDA Label Image

Principal Display Panel (Bupropion Xl Er Tabs 8504 8505 3)

Principal Display Panel (Bupropion Xl Er Tabs 8504 8505 3)
This is a description for a medication package of Bupropion HCI XL in 300 mg extended-release tablets. The package includes several tablets with unique lot numbers. The medication is manufactured by Gravitifor Rising and packaged by Vanguard in Glasgow, Kentucky. The package has instructions to store at 20°-25°C and a warning not to combine with Zyban or other medications containing bupropion HCI. The format of the package is trademarked by Omnicare, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.